Phibro Animal Health Corporation

Phibro Animal Health Corporation carries $788.7M in total debt against $78.1M in cash reserves — debt is roughly 10.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company is burning cash, with free cash flow at -$17.7M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at 30.3%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 8.4% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $942.3M (2022) to $1.30B (2025), reflecting a 38% increase over the period.

PAHC's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Phibro Animal Health Corporation carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Phibro Animal Health Corporation and its sector.